Mesotelioma papilífero bem diferenciado do peritônio: relato de caso e revisão da literatura

Almeida, Daniela Batista de; Freitas, Daniel Meira; Nogueira, José Alberto; Araújo, Iguaracyra Barreto de Oliveira.
J. bras. patol. med. lab ; 41(1): 37-41, fev. 2005. ilus, tab
Artículo en Portugués | LILACS | ID: lil-398071

Documentos relacionados

  1. [Interdisciplinary diagnostics and therapy of malignant mesothelioma].
  2. Surface-Modified Inhaled Microparticle-Encapsulated Celastrol for Enhanced Efficacy in Malignant Pleural Mesothelioma.
  3. Metabolic Effects of New Glucose Transporter (GLUT-1) and Lactate Dehydrogenase-A (LDH-A) Inhibitors against Chemoresistant Malignant Mesothelioma.
  4. Phase I Study of Tremelimumab Monotherapy or in Combination With Durvalumab in Japanese Patients With Advanced Solid Tumors or Malignant Mesothelioma.
  5. A Redox-Silent Analogue of Tocotrienol May Break the Homeostasis of Proteasomes in Human Malignant Mesothelioma Cells by Inhibiting STAT3 and NRF1.
  6. Improvements in Systemic Therapies for Advanced Malignant Mesothelioma.
  7. A Case of Mediastinal Localized Malignant Pleural Mesothelioma Successfully Treated by Chemotherapy and Conversion Surgery.
  8. [Correlation between prognostic nutritional index and pleural thickness with survival time of epithelial malignant pleural mesothelioma patients].
  9. Malignant pleural mesothelioma.
  10. A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment.